Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0000 USD
Change Today 0.00 / 0.00%
Volume 0.0
BIZM On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

biozoom inc (BIZM) Snapshot

Open
$0.0000
Previous Close
$0.0000
Day High
$0.0000
Day Low
$0.0000
52 Week High
10/3/14 - $0.0005
52 Week Low
09/8/14 - $0.0001
Market Cap
600.3
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
60.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOZOOM INC (BIZM)

Related News

No related news articles were found.

biozoom inc (BIZM) Related Businessweek News

No Related Businessweek News Found

biozoom inc (BIZM) Details

Biozoom, Inc. researches, develops, and licenses technologies relating to the mobile remote collection of biomedical data and bi-lateral diagnostic communication. It offers a handheld device that utilizes spectroscopy to measure concentrations of substances in the human body for application in the health, wellness, medical, and chemical industries. The company was founded in 2004 and is headquartered in Kassel, Germany.

biozoom inc (BIZM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $3.8K
Chief Technology Officer and Director
Total Annual Compensation: $3.8K
Compensation as of Fiscal Year 2013.

biozoom inc (BIZM) Key Developments

Lieff Cabraser Announces Class Action Litigation against Biozoom, Inc

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announced that class action litigation has been brought on behalf of those who purchased the common stock of Biozoom, Inc. from market maker KCG Americas LLC on the Over-the-Counter Bulletin Board between May 16, 2013 and June 25, 2013, inclusive. If they purchased Biozoom common stock from KCG on the OTCBB during the Class Period, they may move the Court for appointment as lead plaintiff by no later than July 21, 2014. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. The action alleges that, according to an ongoing action by the Securities and Exchange Commission, between January 2013 and June 2013, certain Argentinean nationals opened U.S. brokerage accounts and deposited millions of shares of unregistered Entertainment Art stock into those accounts. On March 12, 2013, Entertainment Art announced a substantial change in business operations from the development of fashionable leather bags to involvement in the biomedical industry. On April 1, 2013, Entertainment Art changed its name to Biozoom and listed itself on the OTCBB. Beginning on May 23, 2013, Biozoom began issuing a series of press releases claiming it had created the world's first portable, handheld consumer device to instantly measure certain "biomarkers," including anti-oxidant levels, vitamin absorption, and stress levels. After these press releases and certain stock promoters' reiteration of their claims, Biozoom's stock price and trading volume increased significantly. According to the complaint, between May 16, 2013 and June 19, 2013, the Argentinean nationals sold millions of unregistered shares of Biozoom for large profits, however, no registration statement was filed with the SEC in connection with the sales and the sales did not qualify for any exception from registration.

Biozoom, Inc. announced delayed 10-Q filing

On 11/15/2013, Biozoom, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIZM:US $0.00 USD 0.00

BIZM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIZM.
View Industry Companies
 

Industry Analysis

BIZM

Industry Average

Valuation BIZM Industry Range
No financial data is available for BIZM.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOZOOM INC, please visit www.biozoom.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.